详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Application of Various Delivery Methods for CRISPR/dCas9

82| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE ◇ EI

作者：

机构： [1]Department of Clinical Pharmacy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu 610041, Sichuan, China [2]Personalized Drug Therapy Key Laboratory of Sichuan Province, Chengdu, China [3]Sichuan Translational Medicine Hospital, Chinese Academy of Sciences, Chengdu, China [4]Department of Gynecology and Obstetrics, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, China

出处：

DOI：

ISSN：

关键词： CRISPR dCas9 Delivery

摘要：

As gene-editing technology has become more and more popular in the life sciences, CRISPR has brought good news to scientific researchers because of its efficiency, convenience, and wide application. Its wide application has also promoted the development of basic scientific research, agriculture, basic medicine, and clinical treatment. However, how the CRISPR/dCas9 system is effectively delivered to the target organs or cells is still unknown. This paper briefly introduces the CRISPR/dCas9 system and then lists some common delivery methods and their characteristics. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

基金：

基金编号： 30305030698 s.2009SZ0226, 2014FZ0103,2015JQO027,2015ZR0160,20ZDYF1490,and 20CXTD0043 YB2019001 11PPYB010SF-289 s.30305030606and 30305030859 2019-801 201905

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 4 区医学

小类 | 4 区生化与分子生物学 4 区生物工程与应用微生物

最新[2023]版：

大类 | 4 区生物学

小类 | 4 区生化与分子生物学 4 区生物工程与应用微生物

JCR分区：

出版当年[2020]版：

Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

最新[2023]版：

Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

影响因子： 2.4 最新[2023版] 2.6 最新五年平均 2.695 出版当年[2020版] 2.303 出版当年五年平均 2.022 出版前一年[2019版] 2.86 出版后一年[2021版]

第一作者：

第一作者机构： [1]Department of Clinical Pharmacy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu 610041, Sichuan, China [2]Personalized Drug Therapy Key Laboratory of Sichuan Province, Chengdu, China [3]Sichuan Translational Medicine Hospital, Chinese Academy of Sciences, Chengdu, China

共同第一作者：

通讯作者：

通讯机构： [1]Department of Clinical Pharmacy, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu 610041, Sichuan, China [2]Personalized Drug Therapy Key Laboratory of Sichuan Province, Chengdu, China [3]Sichuan Translational Medicine Hospital, Chinese Academy of Sciences, Chengdu, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]CRISPR-Mediated Base Editing: Promises and Challenges for a Viable Oncotherapy Strategy [2]Carrier strategies boost the application of CRISPR/Cas system in gene therapy [3]Characteristics, Recombination methods and Applications progresses of Split-Cas9 System [4]One-step in vivo gene knock-out in porcine embryos using recombinant adeno-associated viruses [5]Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis [6]Multiplex gene regulation by CRISPR-ddCpf1 [7]The CRISPR-Cas system in molecular diagnostics [8]Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation. [9]Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. [10]A systematic CRISPR screen reveals redundant and specific roles for Dscam1 isoform diversity in neuronal wiring